Feasibility - Infinitome

Completed

Conditions studied: Alzheimer Disease

In brief

The Infinitome Program from Omniscient has the ability to identify abnormal brain networks or connectomes using resting state functional MRI (rs-fMRI). This technology, which visualizes brain networks in three dimensions, was originally developed to ensure neurosurgeons avoid inadvertently lesioning cognitively eloquent brain regions during surgical operations. The potential of Infinitome in identifying connectome dysfunction for neurodegenerative diseases such as Alzheimer's disease has yet to be explored. This diagnostic technique may play a critical role for identifying disease brain networks that may benefit from targeted interventions in clinical trials.

Key facts

Study ID

NCT04563767

Run by

HealthPartners Institute

People needed

4

Starts

2020-09-15

Expected to finish

2020-10-13

Last updated by the study team

2021-02-17

Who can join

Age: 40 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a diagnosis of mild, moderate, or severe Alzheimer's disease
• Age: 40 - 90 Years
• Patients who are clinically indicated for an MRI

You may not qualify if…

• fMRI contraindicated (eg. Implantable device, pacemaker, metallic implants, etc.)
• Subject unable to tolerate sitting for a one hour fMRI
• Other concerns as determined by the investigator

Where it is running

• HealthPartners Neuroscience Center — Saint Paul, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.